Nuveen Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.29M | Sell |
288,378
-75,257
| -21% | -$1.9M | ﹤0.01% | 1778 |
|
|
2024
Q3 | $12.4M | Sell |
363,635
-68,245
| -16% | -$2.32M | ﹤0.01% | 1479 |
|
|
2024
Q2 | $16M | Buy |
431,880
+62,797
| +17% | +$2.32M | ﹤0.01% | 1281 |
|
|
2024
Q1 | $15.5M | Buy |
369,083
+247,888
| +205% | +$10.4M | ﹤0.01% | 1328 |
|
|
2023
Q4 | $4.81M | Buy |
121,195
+915
| +0.8% | +$36.3K | ﹤0.01% | 2003 |
|
|
2023
Q3 | $3.31M | Sell |
120,280
-688
| -0.6% | -$18.9K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $4.1M | Buy |
120,968
+420
| +0.3% | +$14.3K | ﹤0.01% | 2013 |
|
|
2023
Q1 | $4.34M | Sell |
120,548
-9,862
| -8% | -$355K | ﹤0.01% | 1973 |
|
|
2022
Q4 | $5.81M | Sell |
130,410
-19,236
| -13% | -$857K | ﹤0.01% | 1826 |
|
|
2022
Q3 | $4.21M | Sell |
149,646
-4,324
| -3% | -$122K | ﹤0.01% | 2002 |
|
|
2022
Q2 | $4.15M | Buy |
153,970
+20,044
| +15% | +$540K | ﹤0.01% | 2065 |
|
|
2022
Q1 | $4.55M | Sell |
133,926
-3,433
| -2% | -$117K | ﹤0.01% | 2111 |
|
|
2021
Q4 | $4.99M | Sell |
137,359
-10,129
| -7% | -$368K | ﹤0.01% | 2114 |
|
|
2021
Q3 | $8.02M | Buy |
147,488
+5,457
| +4% | +$297K | ﹤0.01% | 1931 |
|
|
2021
Q2 | $4.75M | Buy |
+142,031
| New | +$4.75M | ﹤0.01% | 2275 |
|
|
2015
Q2 | – | Sell |
-506
| Closed | -$211K | – | 1499 |
|
|
2015
Q1 | $211K | Buy |
+506
| New | +$211K | ﹤0.01% | 1425 |
|
|
2014
Q2 | – | Sell |
-5,763
| Closed | -$1.53M | – | 1548 |
|
|
2014
Q1 | $1.53M | Sell |
5,763
-234
| -4% | -$62K | 0.01% | 883 |
|
|
2013
Q4 | $2.18M | Buy |
5,997
+419
| +8% | +$152K | 0.01% | 711 |
|
|
2013
Q3 | $2.96M | Buy |
+5,578
| New | +$2.96M | 0.02% | 596 |
|